insights_auto
Why is WUXI06 down 7,96%?
Dive Deeperchevron_right
WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿5,20
arrow_downward
-7,96%(-0,45) 1D
14 Okt., 16:40:00 GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXI06...
Open
฿5,45
High
฿5,45
Low
฿5,20
Mkt. cap
204,77 mjd
Avg. vol.
99,31 k
Volume
165,65 k
52-wk high
฿6,25
52-wk low
฿3,02
Shares outstanding
4,12 mjd
No. of employees
15 k
Open
฿5,45
High
฿5,45
Low
฿5,20
Mkt. cap
204,77 mjd
Avg. vol.
99,31 k
Volume
165,65 k
52-wk high
฿6,25
52-wk low
฿3,02
Shares outstanding
4,12 mjd
No. of employees
15 k
News stories
From web sources and news partners
Simply Wall Street
·
47 minute gelede
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
巴士的報
·
20 minute gelede
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
24/7 Wall St.
·
23 minute gelede
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
Reuters
·
57 minute gelede
Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics (Cayman) Inc. KKPS DR